The case for failed meta‐analyses

Journal of Evaluation in Clinical Practice

Volumn 1, Issue 2, 1995, Pages 127-130

  Naylor, C David ^a,b  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

heterogenedy; meta analysis; overview; random allocation

Indexed keywords

EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS; METHODOLOGY; REPRODUCIBILITY; REVIEW; STANDARD; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 0029395665     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.1995.tb00018.x     Document Type: Article

References (21)

1. Differences in the use of procedures between women and men hospitalized for coronary heart disease
2. Further thoughts on the importance of models in the assessment of official evidence
3. Reporting, updating, and correcting systematic reviews of the effects of health care
4. Meta‐analysis in controlled clinical trials
5. Incorporating variations in the quality of individual randomized trials into meta‐analysis
6. Misleading meta‐analysis
7. Sex differences in the use of invasive coronary procedures in Ontario
8. Meta‐analysis in medicine. Where we are and where we want to go
9. Research by collaboration
10. Grey zones of clinical practice: some limits to evidence‐based medicine
11. Meta‐analysis of controlled clinical trials
12. Two cheers for meta‐analysis. Problems and opportunities in aggregating results of clinical trials
13. Meta‐analysis: reconciling the results of independent studies
14. Users' guides to the medical literature. VI. How to use an overview
15. Coronary artery surgery: are women discriminated against
16. The ‘file drawer problem’ and tolerance for null results
17. Publication bias: the case for an international registry of clinical trials
18. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk in women
19. Magnesium in acute myocardial infarction